#Italy #Menarini Group #Lusochimica #SmartNEBI #Lomania

Lusochimica S.p.A. Receives STEP Seal Award

Lusochimica S.p.A., a subsidiary of the Menarini Group, has made headlines by earning the prestigious STEP Seal from the European Commission. This recognition highlights the potential of groundbreaking projects in the clean technology sector and validates the excellence of their initiatives. The award was granted for their innovative SmartNEBI project, which aims to enhance the sustainability and efficiency of nebivolol synthesis, a well-established active pharmaceutical ingredient (API) used in cardiovascular treatments.

The SmartNEBI project, co-funded by the EU through the EU4Health program, addresses cross-border health challenges with high-quality, innovative healthcare projects. This endorsement marks a significant contribution to the objectives laid out by the Strategic Technology Platforms for Europe (STEP) and acknowledges the project's importance for technological and industrial advancements in Europe.

The core innovation of SmartNEBI lies in the synergistic integration of biocatalysis—where enzymes are utilized as biological catalysts—to facilitate selective, efficient, and eco-friendly chemical transformations. Alongside this, the project employs flow chemistry technology that enables operations to be carried out more effectively and safely, with enhanced heat and mass transfer. The combination of these two advanced methodologies ensures a more productive, scalable, and sustainable synthesis of nebivolol while reducing environmental impact, particularly concerning energy consumption.

Roberto Falorni, the CEO of Lusochimica S.p.A., expressed pride in receiving this recognition, stating, "This award reaffirms Menarini Group's commitment to research and developing innovative solutions for the entire pharmaceutical industry, as well as our grant and funding team's ability to promote our advantages on a European level. SmartNEBI is a strategic initiative for Lusochimica and represents a key step towards more sustainable, safe, and efficient pharmaceutical manufacturing. It focuses on reducing solvent usage, optimizing energy consumption, and enhancing the sustainability of the nebivolol supply chain—an essential medication for the health of millions of patients worldwide."

About Lusochimica S.p.A.

Lusochimica S.p.A. is an Italian company that operates under the Menarini Group, focusing on the production and synthesis of active pharmaceutical ingredients (APIs) while developing scalable manufacturing processes. Headquartered in Lomania, in the province of Lecco, the company manages three production facilities located in Lomania, Pisa, and Casaletto Lodigiano in the province of Lodi. Its manufacturing processes strictly adhere to international cGMP standards.

For more information about Lusochimica, visit lusochimica.it.

About Menarini Group

Menarini Group is a pharmaceutical and diagnostic company based in Florence, active in 140 countries worldwide. With a consolidated turnover of €4.603 billion and a workforce of over 17,000 employees, the group manages nine research and development centers and operates in key therapeutic areas, including cardiology, oncology, gastroenterology, pulmonology, diabetes, and infectious diseases. Menarini manufactures pharmaceuticals in 18 facilities located in Italy and abroad, producing and distributing over 609 million packs annually across five continents. Menarini’s commitment to high-quality production helps improve patients' health globally.

For more details on Menarini Group, visit menarini.com.

Conclusion

The STEP Seal from the European Commission not only recognizes Lusochimica's efforts toward ecological solutions but also sets a benchmark in the pharmaceutical industry for sustainable practices. By prioritizing innovation and development in clean technology initiatives, Lusochimica paves the way for a more sustainable future in medicine production.